Abstract
The aim of the current review is to address updated research on a natural pigment called violacein, with emphasis on its production, biological activity and applications. New information about violacein’s action mechanisms as antitumor agent and about its synergistic action in drug delivery systems has brought new alternatives for anticancer therapy. Thus, violacein is introduced as reliable drug capable of overcoming at least three cancer hallmarks, namely: proliferative signaling, cell death resistance and metastasis. In addition, antimicrobial effects on several microorganisms affecting humans and other animals turn violacein into an attractive drug to combat resistant pathogens. Emphasis is given to effects of violacein combined with different agents, such as antibiotics, anticancer agents and nanoparticles. Although violacein is well-known for many decades, it remains an attractive compound. Thus, research groups have been making continuous effort to help improving its production in recent years, which can surely enable its pharmaceutical and chemical application as multi-task compound, even in the cosmetics and food industries.
Graphic abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Agematu H, Suzuki K, Tsuya H (2011) Massilia sp. BS-1, a novel violacein-producing bacterium isolated from soil. Biosci Biotechnol Biochem 75(10):2008–2010. https://doi.org/10.1271/bbb.100729
Ahmad WA, Yusof NZ, Nordin N, Zakaria ZA, Rezali MF (2012) Production and characterization of violacein by locally isolated Chromobacterium violaceum grown in agricultural wastes. Appl Biochem Biotechnol 167(5):1220–1234. https://doi.org/10.1007/s12010-012-9553-7
Alem D, Marizcurrena JJ, Saravia V, Davyt D, Martinez-Lopez W, Castro-Sowinski S (2020) Production and antiproliferative effect of violacein, a purple pigment produced by an Antarctic bacterial isolate. World J Microbiol Biotechnol 36:120. https://doi.org/10.1007/s11274-020-02893-4
Alshatwi AA, Subash-Babu P, Antonisamy P (2016) Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2. Exp Toxicol Pathol 68:89–97. https://doi.org/10.1016/j.etp.2015.10.002
Antonisamy P, Kannan P, Aravinthan A, Duraipandiyan V, Arasu MV, Ignacimuthu S, Al-Dhabi NA, Kim JH (2014) Gastroprotective activity of violacein isolated from Chromobacterium violaceum on indomethacin-induced gastric lesions in rats: investigation of potential mechanisms of action. Sci World J. https://doi.org/10.1155/2014/616432
Aranda S, Montes-Borrego M, Landa BB (2011) Purple-pigmented violacein-producing Duganella spp. inhabits the rhizosphere of wild and cultivated olives in Southern Spain. Microb Ecol 62:446–459. https://doi.org/10.1007/s00248-011-9840-9
Arif S, Batool A, Khalid N, Ahmed I, Janjua HA (2017) Comparative analysis of stability and biological activities of violacein and starch capped silver nanoparticles. RSC Adv 7:4468–4478. https://doi.org/10.1039/C6RA25806A
Aruldass CA, Rubiyatno VCK, Ahmad WA (2015) Violet pigment production from liquid pineapple waste by Chromobacterium violaceum UTM5 and evaluation of its bioactivity. RSC Adv 5:51524–51536. https://doi.org/10.1039/C5RA05765E
Aruldass CA, Masalamany SRL, Venil CK, Ahmad WA (2018) Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA). Environ Sci Pollut Res 25:5164–5180. https://doi.org/10.1007/s11356-017-8855-2
Atalah J, Blamey L, Munoz-Ibacache S, Gutierrez F, Urzua M, Encinas MV, Páez M, Sun J, Blamey JM (2020) Isolation and characterization of violacein from an Antarctic Iodobacter: a non-pathogenic psychrotolerant microorganism. Extremophiles 24:43–52. https://doi.org/10.1007/s00792-019-01111-w
Avguštin JA, Bertok DZ, Kostanjšek R, Avguštin G (2013) Isolation and characterization of a novel violacein-like pigment producing psychrotrophic bacterial species Janthinobacterium svalbardensis sp. nov”, Antonie van Leeuwenhoek. Int J Gen Mol Microbiol 103:763–769. https://doi.org/10.1007/s10482-012-9858-0
Aye AM, Bonnin-Jusserand M, Brian-Jaisson F, Ortalo-Magne A, Culioli G, Nevry RK, Rabah N, Blache Y, Molmeret M (2015) Modulation of violacein production and phenotypes associated with biofilm by exogenous quorum sensing N-acylhomoserine lactones in the marine bacterium Pseudoalteromonas ulvae TC14. Microbiology 161:2039–2052. https://doi.org/10.1099/mic.0.000147
Bahia AC, Dong Y, Blumberg BJ, Mlambo G, Tripathi A, Ben Marzouk-Hidalgo OJ, Chandra R, Dimopoulos G (2014) Exploring anopheles gut bacteria for plasmodium blocking activity. Environ Microbiol 16:2980–2994. https://doi.org/10.1111/1462-2920.12381
Ballestriero F, Daim M, Penesyan A, Nappi J, Schleheck D, Bazzicalupo P, Di Schiavi E, Egan S (2014) Antinematode activity of violacein and the role of the insulin/IGF-1 pathway in controlling violacein sensitivity in Caenorhabditis elegans. PLoS ONE 8:e109201. https://doi.org/10.1371/journal.pone.0109201
Ballestriero F, Nappi J, Zampi G, Bazzicalupo P, Di Schiavi E, Egan S (2016) Caenorhabditis elegans employs innate and learned aversion in response to bacterial toxic metabolites tambjamine and violacein. Sci Rep 6:29284. https://doi.org/10.1038/srep29284
Barreto ES, Torres AR, Barreto MR, Vasconcelos ATR, Astolfi-Filho S, Hungria M (2008) Diversity in antifungal activity of strains of Chromobacterium violaceum from the Brazilian Amazon. J Ind Microbiol Biotechnol 35:783–790. https://doi.org/10.1007/s10295-008-0331-z
Batista AHM, Moreira ACD, de Carvalho RM, Sales GWP, Nogueira PCN, Grangeiro TB, Medeiros SC, Silveira ER, Nogueira NAP (2017) Antimicrobial effects of violacein against planktonic cells and biofilms of Staphylococcus aureus. Molecules 22:1534. https://doi.org/10.3390/molecules22101534
Batista JH, Leal FC, Fukuda TTH, Alcoforado Diniz J, Almeida F, Pupo MT, da Silva Neto JF (2020) Interplay between two quorum sensing-regulated pathways, violacein biosynthesis and VacJ/Yrb, dictates outer membrane vesicle biogenesis in Chromobacterium violaceum. Environ Microbiol 22(6):2432–2442. https://doi.org/10.1111/1462-2920.15033
Berti IG, Rodenak-Kladniew B, Perez AA, Santiago L, Durán N, Castro RG (2019) Development of biocarrier for violacein controlled release in the treatment of cancer. React Funct Polym 136:122–130. https://doi.org/10.1016/j.reactfunctpolym.2019.01.001
Berti IR, Rodenak-Kladniew BR, Onaindia C, Adam CG, Islan GA, Durán N, Castro GR (2020) Assessment of in vitro cytotoxicity of imidazole ionic liquids and inclusion in targeted drug carriers containing violacein. RSC Adv 10:29336–29346. https://doi.org/10.1039/d0ra05101b
Bettina AM, Doing G, O’Brien K, Perron GG, Jude BA (2018) Draft genome sequences of phenotypically distinct Janthinobacterium sp. isolates cultured from the Hudson Valley Watershed. Genome Announc 6:e01426-e1517. https://doi.org/10.1128/genomeA.01426-17
Bilsland E, Tavella TA, Krogh R, Stokes JE, Roberts A, Ajioka J, David R, Spring DR, Andricopulo AD, Costa FTM, Oliver SG (2018) Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons. BMC Biotechnol 18:22. https://doi.org/10.1186/s12896-018-0428-z
Blackburn MB, Farrar RR Jr, Sparks ME, Kuhar D, Mitchell A, Gundersen-Rindal DE (2017) Chromobacterium sphagni sp. nov., an insecticidal bacterium isolated from Sphagnum bogs. Int J Syst Evol Microbiol 67:3417–3422. https://doi.org/10.1099/ijsem.0.002127
Blackburn MB, Gundersen-Rindal DE, Farrar RR, Kuhar DJ, Mitchell AD (2018) Chromobacterium species with insecticidal activity. US Patent 0103646 A1
Blount BA, Gowers G-OF, Ho JCH, Ledesma-Amaro R, Jovicevic D, McKiernan RM, Xie ZX, Li BZ, Yuan YJ, Ellis T (2018) Rapid host strain improvement by in vivo rearrangement of a synthetic yeast chromosome. Nat Commun 9:1932. https://doi.org/10.1038/s41467-018-03143-w
Boisbaudran LD (1882) Matiere colarante se formant dans la colle de farine. C R Acad Biol 94:562–563
Brazilian National Genome Project Consortium (2003) The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc Natl Acad Sci USA 100:11660–11665. https://doi.org/10.1073/pnas.1832124100
Bromberg N, Dreyfuss JL, Regatieri CV, Palladino MV, Durán N, Nader HB, Haun M, Justo GZ (2010) Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem Biol Interact 186:43–52. https://doi.org/10.1016/j.cbi.2010.04.016
Brucker RM, Baylor CM, Walters RL, Lauer A, Harris RN, Minbiole KPC (2008a) The identification of 2,4-diacetylphloroglucinol as an antifungal metabolite produced by cutaneous bacteria of the salamander Plethodon cinereus. J Chem Ecol 34:39–43. https://doi.org/10.1007/s10886-007-9352-8
Brucker RM, Harris RN, Schwantes CR, Gallaher TN, Flaherty DC, Lam BA, Minbiole KPC (2008b) Amphibian chemical defense: antifungal metabolites of the micro-symbiont Janthinobacterium lividum on the salamander Plethodon cinereus. J Chem Ecol 34:1422–1429. https://doi.org/10.1007/s10886-008-9555-7
Canuto JA, Lima DB, de Menezes R, Batista AHM, Nogueira P, Silveira ER, Grangeiro TB, Nogueira NAP, Martins AMC (2019) Antichagasic effect of violacein from Chromobacterium violaceum. J Appl Microbiol 127:1373–1380. https://doi.org/10.1111/jam.14391
Cardozo VF, Oliveira AG, Nishio EK, Perugini MRE, Andrade CGTJ, Silveira WD, Durán N, Andrade G, Kobayashi RKT, Nakazato G (2013) Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains. Ann Clin Microbiol Antimicrob 12:12. https://doi.org/10.1186/1476-0711-12-12
Cauz ACG, Carretero GPB, Saraiva GKV, Park P, Mortara L, Cuccovia IM, Brocchi M, Gueiros-Filho FJ (2019) Violacein targets the cytoplasmic membrane of bacteria. ACS Infect Dis 5(4):539–549. https://doi.org/10.1021/acsinfecdis.8b00245
Cazotto LL, Martins D, Ribeiro MG, Durán N, Nakazato G (2011) Antibacterial activity of violacein against Staphylococcus aureus from bovine mastitis. J Antibiotics 64:395–397. https://doi.org/10.1038/ja.2011.13
Choi SY, Kim S, Lyuck S, Kim SB, Mitchell RJ (2015a) High-level production of violacein by the newly isolated Duganella violaceinigra str. NI28 and its impact on Staphylococcus aureus. Sci Rep 5:15598. https://doi.org/10.1038/srep15598
Choi SY, Yoon K-H, Lee JI, Mitchell RJ (2015b) Violacein: properties and production of a versatile bacterial pigment. BioMed Res Int 105:465056. https://doi.org/10.1155/2015/465056
Choi SY, Im H, Mitchell RJ (2017) Violacein and bacterial predation: promising alternatives for priority multidrug resistant human pathogens. Future Microbiol 12:835–838. https://doi.org/10.2217/fmb-2017-0090
Choi SY, Lim S, Cho G, Kwon J, Mun W, Im H, Mitchell RJ (2020) Chromobacterium violaceum delivers violacein, a hydrophobic antibiotic, to other microbes in membrane vesicles. Environ Microbiol 20:705–713. https://doi.org/10.1111/1462-2920.14888
Choi SY, Lim S, Yoon KH, Lee JI, Mitchell RJ (2021) Biotechnological activities and applications of bacterial pigments violacein and prodigiosin. J Biol Eng 15(1):10. https://doi.org/10.1186/s13036-021-00262-9
Chuang J, Boeke JD, Mitchell LA (2018) Coupling yeast golden gate and VEGAS for efficient assembly of the violacein pathway in Saccharomyces cerevisiae. In: Jensen MK, Keasling JD (eds) Synthetic metabolic pathways: methods and protocols, methods in molecular biology. Springer, Berlin, pp 211–295
Corazzari M, Fimia GM, Lovat P, Piacentini M (2013) Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications. Semin Cancer Biol 23:337–343. https://doi.org/10.1016/j.semcancer.2013.07.001
Conlon GA, Murray GI (2019) Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol 24:629–640. https://doi.org/10.1002/path.5225
Cress BF, Erkert KA, Barquera B, Koffas MA (2013) Draft genome sequence of Pseudoalteromonas luteoviolacea strain B (ATCC 29581). Genome Announc 1:e0004813. https://doi.org/10.1128/genomeA.00048-13
Dang HT, Yotsumoto K, Enomoto K (2014) Draft genome sequence of violacein-producing marine bacterium Pseudoalteromonas sp. 520P1. Genome Announc 2:e01346-e1414. https://doi.org/10.1128/genomeA.01346-14
de Azevedo MBM, Alderete J, Rodriguez JA, Souza AO, Rettori D, Torsoni MA, Faljoni-Alário A, Haun M, Durán N (2000) Biological activities of violacein: a new antitumoral indole derivative in an inclusion complex with β-cyclodextrin. J Incl Phenom Macrocycl Chem 37:93–101. https://doi.org/10.1023/A:1008138807481
de Carvalho DD, Costa FT, Durán N, Haun M (2006) Cytotoxic activity of violacein in human colon cancer cells. Toxicol in Vitro 20:1514–1521. https://doi.org/10.1016/j.tiv.2006.06.007
de Souza KD, Perez KR, Durán N, Justo GZ, Caseli L (2017) Interaction of violacein in models for cellular membranes: regulation of the interaction by the lipid composition at the air-water interface. Colloids Surf b: Biointerf 160:247–253. https://doi.org/10.1016/j.colsurfb.2017.09.027
DeMoss RD, Evans NR (1959) Physiological aspects of violacein biosynthesis in nonproliferating cells. J Bacteriol 78(4):583–588
DeMoss RD, Evans NR (1960) Incorporation of C14-labeled substrates into violacein. J Bacteriol 79(5):729–733
Devescovi G, Kojic M, Covaceuszach S, Cámara M, Williams P, Bertani I, Subramoni S, Venturi V (2017) Negative regulation of violacein biosynthesis in Chromobacterium violaceum. Front Microbiol 8:349. https://doi.org/10.3389/fmicb.2017.00349
Dodou HV, de Morais Batista AH, Sales GWP, de Medeiros SC, Rodrigues ML, Nogueira PCN, Silveira ER, Nogueira NAP (2017) Violacein antimicrobial activity on Staphylococcus epidermidis and synergistic effect on commercially available antibiotics. J Appl Microbiol 123:853–860. https://doi.org/10.1111/jam.13547
Dodou HV, Batista AHM, Medeiros SC, Sales GWP, Rodrigues ML, Pereira PIO, Nogueira PCN, Silveira ER, Grangeiro TB, Nogueira NAP (2019) Violacein antimicrobial activity on Staphylococcus epidermidis biofilm. Nat Prod Res 13:1–4. https://doi.org/10.1080/14786419.2019.1569654
Doing G, Perron GG, Jude BA (2018) Draft genome sequence of a violacein-producing Iodobacter sp. from the Hudson Valley Watershed. Genome Announc 6:e01428-e1517. https://doi.org/10.1128/genomeA.01428-17
Dong X, Song YN, Liu WG, Guo XL (2009) MMP-9, a potential target for cerebral ischemic treatment. Curr Neuropharmacol 7:269–275. https://doi.org/10.2174/157015909790031157
Durán N, Justo GZ, Ferreira CV, Melo PS, Cordi L, Martins D (2007) Violacein: properties and biological activities. Biotechnol Appl Biochem 48:127–133. https://doi.org/10.1042/BA20070115
Durán M, Ponezi AN, Faljoni-Alario A, Teixeira MFS, Justo GZ, Durán N (2012) Potential applications of violacein: a microbial pigment. Med Chem Res 21:1524–1532. https://doi.org/10.1007/s00044-011-9654-9
Durán N, Justo GZ, Durán M, Brocchi M, Cordi L, Tasic L, Castro GR, Nakazato G (2016) Advances in Chromobacterium violaceum and properties of violacein, its main secondary metabolite: a review. Biotechnol Adv 34:1030–1045. https://doi.org/10.1016/j.biotechadv.2016.06.003
Durán N, Fávaro WJ, Brocchi M, Justo GZ, Castro GR, Durán M, Nakazato G (2020) Patents on violacein: a compound with great diversity of biological activities and industrial potential. Recent Pat Biotechnol. https://doi.org/10.2174/2213476X07666201221111655
Fakhr FA, Khanafari A, Baserisalehi M, Yaghoobi RF, Shahghasempour S (2012) An investigation of antileukemia activity of violacein loaded dendrimer in Jurkat cell lines. Afr J Microbiol Res 6:6235–6242. https://doi.org/10.5897/AJMR11.741
Fang M-Y, Zhang C, Yang S, Cui J-Y, Jiang P-X, Lou K, Wachi M, Xing X-H (2015) High crude violacein production from glucose by Escherichia coli engineered with interactive control of tryptophan pathway and violacein biosynthetic pathway. Microb Cell Fact 14:8. https://doi.org/10.1186/s12934-015-0192-x
Fang M, Wang T, Zhang C, Bai J, Zheng X, Zhao X, Lou K, Xing X-H (2016) Intermediate-sensor assisted push-pull strategy and its application in heterologous deoxyviolacein production in Escherichia coli. Metab Eng 33:41–51. https://doi.org/10.1016/j.ymben.2015.10.006
Farrar RR, Gundersen-Rindal DE, Kuhar D, Blackburn MB (2018) Insecticidal activity of Chromobacterium vaccinii. J Entomol Sci 53:339–346. https://doi.org/10.18474/JES17-108.1
Ferreira CV, Bos CL, Versteeg HH, Justo GZ, Durán N, Peppelenbosch MP (2004) Molecular mechanism of violacein-mediated human leukemia cell death. Blood 104:1459–1464. https://doi.org/10.1182/blood-2004-02-0594
Füller JJ, Röpke R, Krausze J, Rennhack KE, Daniel N, Blankenfeldt W, Schulz S, Jahn D, Moser J (2016) Biosynthesis of violacein: structure and function of L-tryptophan oxidase VioA from Chromobacterium violaceum. J Biol Chem 291:20068–20084. https://doi.org/10.1074/jbc.M116.741561
Gao A, Chen H, Hou A, Xie K (2019) Efficient antimicrobial silk composites using synergistic effects of violacein and silver nanoparticles. Mater Sci Eng C Mater Biol Appl 103:109821. https://doi.org/10.1016/j.msec.2019.109821
Gomez-Gomez B, Arregui L, Serrano S, Santos A, Perez-Corona T, Madrid Y (2019) Selenium and tellurium-based nanoparticles as interfering factors in quorum sensing-regulated processes: violacein production and bacterial biofilm formation. Metallomics 11:1104–1114. https://doi.org/10.1039/C9MT00044E
Gonçalves PR, Rocha-Brito KJP, Fernandes MRN, Abrantes JL, Durán N, Ferreira-Halder CV (2016) Violacein induces death of RAS-mutated metastatic melanoma by impairing autophagy process. Tumor Biol 37:14049–14058. https://doi.org/10.1007/s13277-016-5265-x
Gupta R, Mitra S, Chowdhury S, Das G, Priyadarshini R, Mukhopadhyay MK, Ghosh SK (2021) Discerning perturbed assembly of lipids in a model membrane in presence of violacein. Biochim Biophys Acta Biomembr 1863:183647. https://doi.org/10.1016/j.bbamem.2021.183647
Hakvåg S, Fjaervik E, Klinkenberg G, Borgos SE, Josefsen KD, Ellingsen TE, Zotchev SB (2009) Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trøndelag. Norway Mar Drugs 7:576–588. https://doi.org/10.3390/md7040576
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70. https://doi.org/10.1016/s0092-8674(00)81683-9
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013
Harris RN, Brucker RM, Walke JB, Becker MH, Schwantes CR, Flaherty DC, Lam BA, Woodhams DC, Briggs CJ, Vredenburg VT, Minbiole KPC (2009) Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus. ISME J 3:818–824. https://doi.org/10.1038/ismej.2009.27
Harvey AL, Edrada-Ebel R, Quinn RJ (2015) The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 14:111–129. https://doi.org/10.1038/nrd4510
Hashimi SM, Xu T, Wei MQ (2015) Violacein anticancer activity is enhanced under hypoxia. Oncol Rep 33:1731–1736. https://doi.org/10.3892/or.2015.3781
Hidachi K, Mitsuishi S, Ueno M, Toda K, Yuki H, Takiguchi Y, Sasaki O, Tomiyama M, Kawakami R, Sakai A, Sakurai T, Yasukawa T, Abe J, Ogata H (2017) Tyrosinase activity inhibitor. Japan Patent 2017210451
Hoshino T (2011) Violacein and related tryptophan metabolites produced by Chromobacterium violaceum: biosynthetic mechanism and pathway for construction of violacein core. Appl Microbiol Biotechnol 91:1463–1475. https://doi.org/10.1007/s00253-011-3468-z
Im H, Choi SY, Son S, Mitchell RJ (2017) Combined application of bacterial predation and violacein to kill polymicrobial pathogenic communities. Sci Rep 7:14415. https://doi.org/10.1038/s41598-017-14567-7
Immanuel SRC, Banerjee D, Rajankar MP, Raghunathan A (2018) Integrated constraints based analysis of an engineered violacein pathway in Escherichia coli. Biosystems 171:10–19. https://doi.org/10.1186/s12918-017-0427-z
Islan GA, Durán M, Cacicedo ML, Nakazato G, Kobayashi RKT, Martinez DST, Castro GR, Durán N (2017) Nanopharmaceuticals as a solution to neglected diseases: is it possible? Acta Trop 170:16–42. https://doi.org/10.1016/j.actatropica.2017.02.019
Jones JA, Vernacchio VR, Lachance DM, Lebovich M, Fu L, Shirke AN, Schultz VL, Cress B, Linhardt RJ, Koffas MAG (2015) ePathOptimize: a combinatorial approach for transcriptional balancing of metabolic pathways. Sci Rep 5:11301. https://doi.org/10.1038/srep11301
Jude BA (2019) Draft genome sequence of a Chitinimonas species from Hudson Valley waterways that expresses violacein pigment. Microbiol Resour Announc 8:e00683-e719. https://doi.org/10.1128/MRA.00683-19
Justo GZ, Durán N (2017) Action and function of Chromobacterium violaceum in health and disease: violacein as a promising metabolite to counteract gastroenterological disease. Best Pract Res Clin Gastroenterol 31:649–656. https://doi.org/10.1016/j.bpg.2017.10.002
Kallmayer V, Lanzendoerfer G, Meiring U, Mocigemba N, Reidel H, Schaefer J, Viala S (2005) Cosmetic preparation, useful e.g. for the protection of skin and (semi)mucous membrane against bacteria and/or virus, comprises violacein dye in combination with lipophilic and/or hydrophilic substances. Germany Patent DE102005051869 A1
Kanelli M, Mandic M, Kalakona M, Vasilakos S, Kekos D, Nikodinovic-Runic J, Topakas E (2018) Microbial production of violacein and process optimization for dyeing polyamide fabrics with acquired antimicrobial properties. Front Microbiol 9:1495. https://doi.org/10.3389/fmicb.2018.01495
Kato K, Yasui T, Akira S, Tsukamoto T, Qin H, Atsushi K (1998) Bluish purple pigment produced by bacterium and its use as dye or coloring additive. Japan Patent 10113169
Kodach LL, Bos CL, Durán N, Peppelenbosch MP, Ferreira CV, Hardwick JCH (2006) Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis 27:508–516. https://doi.org/10.1093/carcin/bgi307
Kothari V, Sharma S, Padia D (2017) Recent research advances on Chromobacterium violaceum. Asian Pac J Trop Med 10:744–752. https://doi.org/10.1016/j.apjtm.2017.07.022
Kuzyk SB, Pritchard AO, Plouffe J, Sorensen JL, Yurkov V (2020) Psychrotrophic violacein-producing bacteria isolated from Lake Winnipeg, Canada. J Great Lakes Res. https://doi.org/10.1016/j.jglr.2020.04.008
Lakhan SE, Kirchgessner A, Tepper D, Leonard A (2013) Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol 4:32. https://doi.org/10.3389/fneur.2013.00032
Lamendella R, Jude BA (2018) Draft genome sequences of violacein-producing Duganella sp. isolates from a waterway in eastern Pennsylvania. Microbiol Resour Announc 7:e01196-e1218. https://doi.org/10.1128/MRA.01196-18
Leal AMS, de Queiroz JDF, de Medeiros SRB, Lima TKS, Agnez-Lima LF (2015) Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro. BMC Microbiol 15:115. https://doi.org/10.1186/s12866-015-0452-2
Lee JK, Kwak HJ, Piao MS, Jang JW, Kim SH, Kim HS (2010) Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats. Acta Neurochir (wien) 153:1321–1329. https://doi.org/10.1007/s00701-010-0889-x
Lee ME, Aswani A, Han AS, Tomlin CJ, Dueber JE (2013) Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay. Nucleic Acids Res 41:10668–10678. https://doi.org/10.1093/nar/gkt809
Lee YJ, Bashyal P, Pandey RP, Sohng JK (2019) Enzymatic and microbial biosynthesis of novel violacein glycosides with enhanced water solubility and improved anti-nematode activity. Biotechnol Bioproc Eng 24(2):366–374. https://doi.org/10.1007/s12257-018-0466-3
Leon LL, Miranda CC, De Souza AO, Durán N (2001) Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. J Antimicrob Chemother 48:449–450. https://doi.org/10.1093/jac/48.3.449
Linger RM, Cohen RA, Cummings CT, Sather S, Migdall-Wilson J, Middleton DH, Lu X, Barón AE, Franklin WA, Merrick DT, Jedlicka P, DeRyckere D, Heasley LE, Graham DK (2013) Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene 32:3420–3431. https://doi.org/10.1038/onc.2012.355
Liu L, Lu J, Wang Y, Pang XY, Xu M, Zhang SW, Lu JP (2017) Antitumor effect of violacein against HT29 by comparative proteomics. Sci Agric Sinica 50:1604–1704. https://doi.org/10.3864/j.issn.0578-1752.2017.09.015
Lopes SCP, Blanco YC, Justo GZ, Nogueira PA, Rodrigues FLS, Goelnitz U, Wunderlich G, Facchini G, Brocchi M, Durán N, Costa FTM (2009) Violacein extracted from Chromobacterium violaceum inhibits plasmodium growth in vitro and in vivo. Antimicrob Agents Chemother 53:2149–2152. https://doi.org/10.1128/AAC.00693-08
Lozano GL, Guan C, Cao Y, Borlee BR, Broderick NA, Stabb EV, Handelsman J (2020) A chemical counterpunch: Chromobacterium violaceum ATCC 31532 produces violacein in response to translation-inhibiting antibiotics. Mbio 11(3):e00948-e01020. https://doi.org/10.1128/mBio.00948-20
Martin PA, Soby S (2016) Insecticidal strains of Chromobacterium vaccinii sp. nov. for control of insects. US Patent 9,339,039 B1
Martin PA, Gundersen-Rindal D, Blackburn M, Buyer J (2007) Chromobacterium subtsugae sp. nov., a betaproteobacterium toxic to Colorado potato beetle and other insect pests. Int J Syst Evol Microbiol 57:993–999. https://doi.org/10.1099/ijs.0.64611-0
Masuelli L, Pantanella F, La Regina G, Benvenuto M, Fantini M, Mattera R, Di Stefano E, Mattei M, Silvestri R, Schippa S, Manzari V, Modesti A, Bei R (2016) Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo. Tumour Biol 37(3):3705–3717. https://doi.org/10.1007/s13277-015-4207-3
Matz C, Deines P, Boeings J, Arndt H, Eberl L, Kjelleberg S, Jürgens K (2004) Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl Environ Microbiol 70:1593–1599. https://doi.org/10.1128/aem.70.3.1593-1599.2004
Matz C, Webb JS, Schupp PJ, Phang SY, Penesyan A, Egan S, Peter Steinberg P, Kjelleberg S (2008) Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS ONE 3:e2744. https://doi.org/10.1371/journal.pone.0002744
Melo PS, Justo GZ, de Azevedo MB, Durán N, Haun M (2003) Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells. Toxicology 186:217–225. https://doi.org/10.1016/s0300-483x(02)00751-5
Mojib N, Nasti TH, Andersen DT, Attigada VR, Hoover RB, Yusuf N, Bej AK (2011) The antiproliferative function of violacein-like purple violet pigment (PVP) from an Antarctic Janthinobacterium sp. Ant5-2 in UV-induced 2237 fibrosarcoma. Int J Dermatol 5:1223–1233. https://doi.org/10.1111/j.1365-4632.2010.04825.x
Myeong NR, Seong HJ, Kim HJ, Sul WJ (2016) Complete genome sequence of antibiotic and anticancer agent violacein producing Massilia sp. strain NR 4–1. J Biotechnol 223:36–37. https://doi.org/10.1016/j.jbiotec.2016.02.027
Nakazato G, Gonçalves MC, das Neves MS, Kobayashi RKT, Brocchi M, Durán N (2019) Violacein@Biogenic Ag system: synergistic antibacterial activity against Staphylococcus aureus. Biotechnol Lett 41:1433–1437. https://doi.org/10.1007/s10529-019-02745-8
Nathwani D, Eckmann C, Lawson W, Solem CT, Corman S, Stephens JM, Macahilig C, Simoneau D, Chambers R, Li JZ, Haider S (2014) Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe. BMC Infect Dis 14:476. https://doi.org/10.1186/1471-2334-14-476
Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629–661. https://doi.org/10.1021/acs.jnatprod.5b01055
Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 83(3):770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
Newman DJ, Cragg GM, Snader KM (2000) The influence of natural products upon drug discovery. Nat Prod Rep 17:215–234. https://doi.org/10.1039/a902202c
Numan M, Bashir S, Mumtaz R, Tayyab S, Rehman NU, Khan AL, Shinwari ZK, Al-Harrasi A (2018) Therapeutic applications of bacterial pigments: a review of current status and future opportunities. 3 Biotech 8:207. https://doi.org/10.1007/s13205-018-1227-x
Pandey AK, Verma S, Bhattacharya P, Paul S, Mishra A, Patnaik R (2012) An in-silico strategy to explore neuroprotection by quercetin in cerebral ischemia: a novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a). Med Hypotheses 79:76–81. https://doi.org/10.1016/j.mehy.2012.04.005
Pandey AK, Bhattacharya P, Shukla SC, Paul S, Patnaik R (2015) Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection. Neural Regen Res 10:568–575. https://doi.org/10.4103/1673-5374.155429
Park HA, Park SA, Yang Y-H, Choi K-Y (2021) Microbial synthesis of violacein pigment and its potential applications. Crit Rev Biotechnol. https://doi.org/10.1080/07388551.2021.1892579
Pauer H, Hardoim CCP, Teixeira FL, Miranda KR, Barbirato DS, Pires de Carvalho DP, Antunes LCM, Leitão AAC, Lobo LA, Domingues RMCP (2018) Impact of violacein from Chromobacterium violaceum on the mammalian gut microbiome. PLoS ONE 13:e0203748. https://doi.org/10.1371/journal.pone.0203748
Platt D, Amara S, Mehta T, Vercuyssee K, Myles EL, Johnson T, Tiriveedhi V (2014) Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis. Biochem Biophys Res Commun 455:107–112. https://doi.org/10.1016/j.bbrc.2014.10.124
Priya D, Kannan SRS, Thanga MK (2018) Production of violacein pigment from Chromobacterium violaceum and its antibacterial activity and synergism on E. coli isolated from UTI samples. Int J Recent Sci Res 9:24479–24484. https://doi.org/10.24327/ijrsr.2018.0902.1669
Puranik S, Talkal R, Qureshi A, Khardenavis A, Kapley A, Purohit HJ (2013) Sequence of the pigment-producing bacterium Pseudogulbenkiania ferrooxidans, isolated from Loktak Lake. Genome Announc 1:e01115-e1213. https://doi.org/10.1128/genomeA.01115-13
Queiroz KC, Milani R, Ruela-de-Sousa RR, Fuhler GM, Justo GZ, Zambuzzi WF, Duran N, Diks SH, Spek CA, Ferreira CV, Peppelenbosch MP (2012) Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse. PLoS ONE 7:e45362. https://doi.org/10.1371/journal.pone.0045362
Rahul S, Chandrashekhar P, Hemant B, Bipinchandra S, Mouray E, Grellier P, Patil S (2015) In vitro antiparasitic activity of microbial pigments and their combination with phytosynthesized metal nanoparticles. Parasitol Int 64:353–356. https://doi.org/10.1016/j.parint.2015.05.004
Ramirez JL, Short SM, Bahia AC, Saraiva RG, Dong Y, Kang S, Tripathi A, Mlambo G, Dimopoulos G (2014) Chromobacterium Csp_P reduces malaria and dengue infection in vector mosquitoes and has entomopathogenic and in vitro anti-pathogen activities. PLoS Patholog 10:e1004398. https://doi.org/10.1371/journal.ppat.1004398
Ran T, Gao M, Wei Q, He J, Tang L, Wang W, Xu D (2015) Expression, crystallization and preliminary crystallographic data analysis of VioD, a hydroxylase in the violacein-biosynthesis pathway. Acta Crystal Sect F Struct Biol Commun 71:149–152. https://doi.org/10.1107/s2053230x14027617
Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020–1030. https://doi.org/10.1161/01.str.29.5.1020
Rongzhen X, Yuwen W (2017) Use of natural pigment as nail polish pigment enabling to develop a healthy and environmentally friendly nail polish pigment. Taiwan Patent TW I570191
Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775–787. https://doi.org/10.1016/j.cell.2008.05.009
Santos AB, Costa PS, do Carmo AO, da Rocha Fernandes G, Scholte LLS, Ruiz J, Kalapothakis E, Chartone-Souza E, Nascimento AMA (2018) Insights into the genome sequence of Chromobacterium amazonense isolated from a tropical freshwater lake. Int J Genomics. https://doi.org/10.1155/2018/1062716
Sarkar J, Nandy SK, Chowdhury A, Chakrabor T, Chakrabor S (2016) Inhibition of MMP-9 by green tea catechins and prediction of their interaction by molecular docking analysis. Biomed Pharmacother 84:340–347. https://doi.org/10.1016/j.biopha.2016.09.049
Sarmiento JJP, Cardozo VF, Durán N, Brocchi M, Kobayashi RKT, Nakazato G (2016) Composição contendo nanopartículas de prata biológica e um pigmento produzido por Chromobacterium violaceum com atividade antibacteriana. Brazilian Patent PIBR-10 003373 0
Sasidharan A, Sasidharan NK, Amma DBNS, Vasu RK, Nataraja AV, Bhaskaran K (2015) Antifungal activity of violacein purified from a novel strain of Chromobacterium sp. NIIST (MTCC 5522). J Microbiol 53:694–701. https://doi.org/10.1007/s12275-015-5173-6
Satoshi A, Takatoshi N (1998) Production of natural antimicrobial antioxidant and its cosmetic formulation. Japan Patent 10139612
Savage VJ, Chopra I, O’Neill AJ (2013) Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother 57:1968–1970. https://doi.org/10.1128/AAC.02008-12
Schaeffer N, Kholany M, Veloso TLM, Pereira JL, Ventura SPM, Nicaud JM, Coutinho JAP (2019) Temperature-responsive extraction of violacein using a tuneable anionic surfactant-based system. Chem Commun (camb) 55(59):8643–8646. https://doi.org/10.1039/c9cc03831k
Scheele BC, Pasmans F, Skerratt LF, Berger L, Martel A, Beukema W, Acevedo AA, Burrowes PA, Carvalho T, Catenazzi A, De la Riva I, Fisher MC, Flechas SV, Foster CN, Frías-Álvarez P, Garner TWJ, Gratwicke B, Guayasamin JM, Hirschfeld M, Kolby JE, Kosch TA, La Marca E, Lindenmayer DB, Lips KR, Longo AV, Maneyro R, McDonald CA, Mendelson J 3rd, Palacios-Rodriguez P, Parra-Olea G, Richards-Zawacki CL, Rödel MO, Rovito SM, Soto-Azat C, Toledo LF, Voyles J, Weldon C, Whitfield SM, Wilkinson M, Zamudio KR, Canessa S (2019) Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity. Science 363:1459–1463. https://doi.org/10.1126/science.aav0379
Schreiber SL, Nicolaou KC, Davies K (2002) Diversity-oriented organic synthesis and proteomics. New frontiers for chemistry & biology. Chem Biol 9:1–2. https://doi.org/10.1016/s1074-5521(02)00088-1
Smith HJ, Foreman CM, Akiyama T, Franklin MJ, Devitt NP, Ramaraj T (2016) Genome sequence of Janthinobacterium sp. CG23_2, a violacein-producing isolate from an Antarctic supraglacial stream. Genome Announc 4:e01468-e1515. https://doi.org/10.1128/genomeA.01468-15
Subramaniam S, Ravi V, Sivasubramanian A (2014) Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms. Pharm Biol 52:86–90. https://doi.org/10.3109/13880209.2013.815634
Tapia MAD, Herrera JRO, Quiroga CJI (2012) Strain of Cobetia marina and biosurfactant extract obtained from same. European Patent EP2716749
Thøgersen MS, Delpin MW, Melchiorsen J, Kilstrup M, Månsson M, Bunk B, Sproer C, Overmann J, Nielsen KF, Gram L (2016) Production of the Bioactive compounds violacein and indolmycin is conditional in a maeA mutant of Pseudoalteromonas luteoviolacea S4054 lacking the malic enzyme. Front Microbiol 7:1461. https://doi.org/10.3389/fmicb.2016.01461
Thomé R, Moraes AS, Bombeiro AL, Farias A, Francelin C, da Costa TA, Di Gangi R, Santos LMB, de Oliveira ALR, Verinaud L (2013) Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis. PLoS ONE 8:e65913. https://doi.org/10.1371/journal.pone.0065913
Thomé R, Issayama LK, DiGangi R, Bombeiro AL, da Costa TA, Ferreira IT, de Oliveira ALR, Machado DRS, Verinaud L (2014) Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis. Immunol Cell Biol 92:124–132. https://doi.org/10.1038/icb.2013.73
Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287–296. https://doi.org/10.1084/jem.188.2.287
Tobie WC (1935) The pigment of Bacillus violaceus. I. The production, extraction, and purification of violacein. J Bacteriol 29(3):223–227
Tong Y, Zhou J, Zhang L, Xu P (2021) A golden-gate based cloning toolkit to build violacein pathway libraries in Yarrowia lipolytica. ACS Synth Biol 10(1):115–124. https://doi.org/10.1021/acssynbio.0c00469
Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Res 6:750. https://doi.org/10.12688/f1000research.11120.1
Valdes N, Soto P, Cottet L, Alarcon P, Gonzalez A, Castillo A, Corsini G, Tello M (2015) Draft genome sequence of Janthinobacterium lividum strain MTR reveals its mechanism of capnophilic behavior. Stand Genomic Sci 10:110. https://doi.org/10.1186/s40793-015-0104-z
Venegas FA, Kollisch G, Mark K, Diederich WE, Kaufmann A, Bauer S, Max Chavarría M, Juan J, Araya JJ, Alfonso J, García-Piñeres AJ (2019) The bacterial product violacein exerts an immunostimulatory effect via TLR8. Sci Rep 9:13661. https://doi.org/10.1038/s41598-019-50038-x
Venil CK, Aruldass CA, Halim MHA, Khasim AR, Zakaria ZA, Ahmad WA (2015) Spray drying of violet pigment from Chromobacterium violaceum UTM 5 and its application in food model systems. Int Biodeterior Biodegrad 102:324–329. https://doi.org/10.1016/j.ibiod.2015.02.006
Verma S, Pandey AK (2017) An in-silico approach to explore the possible multifunctional neuroprotective efficacy of violacein against ischemic stroke. J Pharmacol 3:17. https://doi.org/10.21767/2469-6692.100017
Verma A, Warner SL, Vankayalapati H, Bearss DJ, Sharma S (2011) Targeting Axl and Mer kinases in cancer. Mol Cancer Ther 10:1763–1773. https://doi.org/10.1158/1535-7163.MCT-11-0116
Verinaud L, Lopes SCP, Prado ICN, Zanucoli F, da Costa TA, Di Gangi R, Issayama LK, Carvalho AC, Bonfanti AP, Niederauer GF, Durán N, Costa FTM, de Oliveira ALR, Thomé R (2015) Violacein treatment modulates acute and chronic inflammation through the suppression of cytokine production and induction of regulatory T cells. PLoS ONE 10:e0125409. https://doi.org/10.1371/journal.pone.0125409
Vöing K, Harrison A, Soby SD (2015) Draft genome sequence of Chromobacterium vaccinii, a potential biocontrol agent against mosquito (Aedes aegypti) larvae. Genome Announc 3:e00477–e00515. https://doi.org/10.1128/genomeA.00477-15
Vöing K, Harrison A, Soby SD (2017) Draft genome sequence of Chromobacterium subtsugae MWU12-2387 isolated from a Wild Cranberry Bog in Truro, Massachusetts. Genome Announc 5:e01633-e1716. https://doi.org/10.1128/genomeA.01633-16
Woodhams DC, LaBumbard BC, Barnhart KL, Becker MH, Bletz MC, Escobar LA, Flechas SV, Forman ME, Iannetta AA, Joyce MD, Rabemananjara F, Gratwicke B, Vences M, Minbiole KPC (2018) Prodigiosin, violacein, and volatile organic compounds Produced by widespread cutaneous bacteria of amphibians can inhibit two Batrachochytrium fungal pathogens. Microb Ecol 75:1049–1062. https://doi.org/10.1007/s00248-017-1095-7
World Health Organization (2017) World malaria report 2017. pp 197. https://www.who.int/malaria/publications/world-malaria-report-2017/en/. Accessed 28 Sept 2020
Wu YH, Cheng H, Xu L, Jin XB, Wang CS, Xu XW (2017) Physiological and genomic features of a novel violacein-producing bacterium isolated from surface seawater. PLoS ONE 12(6):e0179997. https://doi.org/10.1371/journal.pone.0179997
Xu X, Tian L, Zhang S, Jiang L, Zhang Z, Huang H (2019) Complete genome sequence of Janthinobacterium sp. B9–8, a violacein-producing bacterium isolated from low-temperature sewage. Microb Pathog 128:178–183. https://doi.org/10.1016/j.micpath.2019.01.003
Yoon KH, Lee TY, Moon JH, Choi SY, Choi YJ, Mitchell RJ, Il Lee J (2020) Consumption of oleic acid during matriphagy in free-living nematodes alleviates the toxic effects of the bacterial metabolite violacein. Sci Rep 10(1):8087. https://doi.org/10.1038/s41598-020-64953-x
Zhou Y, Fang MY, Li G, Zhang C, Xing XH (2018) Enhanced production of crude violacein from glucose in Escherichia coli by overexpression of rate-limiting key enzyme(s) involved in violacein biosynthesis. Appl Biochem Biotechnol 186:909–916. https://doi.org/10.1007/s12010-018-2787-2
Acknowledgements
The authors thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for scholarships and sponsorship of projects that enabled our research and literature access.
Author information
Authors and Affiliations
Contributions
All the authors cooperated in the formal analysis, writing, reviewing and editing the original draft. GZJ and ND cooperated in the conceptualization and final revision of the manuscript. GZJ edited the final version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Durán, N., Nakazato, G., Durán, M. et al. Multi-target drug with potential applications: violacein in the spotlight. World J Microbiol Biotechnol 37, 151 (2021). https://doi.org/10.1007/s11274-021-03120-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11274-021-03120-4